Acepodia Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE2016, a First-in-Class Allogeneic Anti-EGFR Cell Therapy Posted on 2024-02-042024-03-13 by maxproadmin More >>
Anbogen Anbogen Secures $12.5 Million USD in Series A Funding, Advancing Precision Oncology Drug Development Posted on 2024-02-012024-03-15 by maxproadmin More >>